EPO and retinopathy of prematurity: Longitudinal clinical studies, including the recent PENUT trial, examined the efficacy of high dose exogenous EPO in preterm infants.34,35 These studies did not observe a significant difference in the neurodevelopmental outcomes or rates of ROP in preterm infants administered exogenous EPO compared to placebo.